MettlerToledo International Inc (0K10.L)

Healthcare | Medical Pharmaceuticals
Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$1.1B

Net Income

$286M

Operating Margin

30.4%

Free Cash Flow

$849M

Debt / Assets

100.6%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for MettlerToledo International Inc (0K10.L).
Income Statement (Quarterly) 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Revenue 1,129,735,000 1,029,699,000 983,221,000 883,744,000
Cost of Revenue 473,973,000 440,265,000 420,926,000 375,058,000
Gross Profit 655,762,000 589,434,000 562,295,000 508,686,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 259,826,000 248,391,000 247,298,000 242,799,000
Operating Expenses 312,425,000 299,534,000 296,583,000 289,145,000
Operating Income 343,337,000 289,900,000 265,712,000 219,541,000
Interest Expense 17,388,000 17,695,000 16,779,000 16,653,000
Income Before Tax 329,074,000 269,236,000 248,657,000 201,942,000
Income Tax Expense 43,309,000 51,743,000 46,309,000 38,355,000
Net Income 285,765,000 217,493,000 202,348,000 163,587,000
Per Share
EPS 14.02 10.60 9.77 7.84
EPS Diluted 0.00 0.00 0.00 0.00